Pages that link to "Q81648334"

The following pages link to Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients (Q81648334):

Displaying 23 items.

• Systemic therapies for pancreatic cancer--the role of pharmacogenetics (Q27021716) (← links)
• Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma (Q28385950) (← links)
• Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma (Q34017423) (← links)
• Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer (Q34083752) (← links)
• Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck (Q34159125) (← links)
• Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer (Q35120828) (← links)
• Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study (Q35602143) (← links)
• EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy (Q36103054) (← links)
• Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan (Q36111221) (← links)
• Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma (Q36400027) (← links)
• Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action (Q36475391) (← links)
• Combination of radiotherapy with EGFR antagonists for head and neck carcinoma (Q36795322) (← links)
• Epidermal growth factor receptor in pancreatic cancer. (Q37132640) (← links)
• Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer (Q37321897) (← links)
• Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors. (Q37579644) (← links)
• Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer (Q37707275) (← links)
• Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro (Q39957730) (← links)
• Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma (Q40974026) (← links)
• Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors (Q42545098) (← links)
• Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib. (Q53564370) (← links)
• Epidermal Growth Factor Receptor Protein Detection in Head and Neck Cancer Patients: A Many-Faceted Picture (Q54537667) (← links)
• Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target? (Q80051640) (← links)
• EGFR: a prognostic and/or a predictive marker? (Q80100754) (← links)